| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analogue insulin as an essential medicine: the need for more evidence and lower prices
|
Beran, David
|
|
2019
|
7 |
5 |
p. 338
|
artikel
|
| 2 |
Change in albuminuria as a surrogate endpoint in chronic kidney disease
|
Zhao, Hai-Lu
|
|
2019
|
7 |
5 |
p. 335-336
|
artikel
|
| 3 |
Change in albuminuria as a surrogate endpoint in chronic kidney disease
|
Pyne, Lonnie
|
|
2019
|
7 |
5 |
p. 335
|
artikel
|
| 4 |
Change in albuminuria as a surrogate endpoint in chronic kidney disease – Authors' reply
|
Heerspink, Hiddo J L
|
|
2019
|
7 |
5 |
p. 336-337
|
artikel
|
| 5 |
Correction to Lancet Diabetes Endocrinol 2017; 5: 877–86
|
|
|
2019
|
7 |
5 |
p. e5
|
artikel
|
| 6 |
Correction to Lancet Diabetes Endocrinol 2019; 7:288–99
|
|
|
2019
|
7 |
5 |
p. e5
|
artikel
|
| 7 |
Correction to Lancet Diabetes Endocrinol 2016; 4: 633–35
|
|
|
2019
|
7 |
5 |
p. e5
|
artikel
|
| 8 |
Correction to Lancet Diabetes Endocrinol 2018; published online Dec 19. https://doi.org/10.1016/S2213-8587(18)30263-8
|
|
|
2019
|
7 |
5 |
p. e5
|
artikel
|
| 9 |
Correction to Lancet Diabetes Endocrinol 2019; published online March 1. DOI:10.1016/ S2213-8587(19)30066-X
|
|
|
2019
|
7 |
5 |
p. e5
|
artikel
|
| 10 |
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
|
Lean, Michael E J
|
|
2019
|
7 |
5 |
p. 344-355
|
artikel
|
| 11 |
EDCs: regulation still lagging behind evidence
|
The Lancet Diabetes & Endocrinology,
|
|
2019
|
7 |
5 |
p. 325
|
artikel
|
| 12 |
Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial
|
Estruch, Ramon
|
|
2019
|
7 |
5 |
p. e6-e17
|
artikel
|
| 13 |
Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial
|
Boughton, Charlotte K
|
|
2019
|
7 |
5 |
p. 368-377
|
artikel
|
| 14 |
GLP-1 and the renin–angiotensin–aldosterone system
|
Jiménez, David León
|
|
2019
|
7 |
5 |
p. 337
|
artikel
|
| 15 |
Glucose screening in pregnancy and future risk of cardiovascular disease in women: a retrospective, population-based cohort study
|
Retnakaran, Ravi
|
|
2019
|
7 |
5 |
p. 378-384
|
artikel
|
| 16 |
Glycaemic control on nutritional support: finding stability in unstable times
|
Gillard, Pieter
|
|
2019
|
7 |
5 |
p. 330-331
|
artikel
|
| 17 |
Health care and mental wellbeing in the transgender and gender-diverse Chinese population
|
Zhu, Xuequan
|
|
2019
|
7 |
5 |
p. 339-341
|
artikel
|
| 18 |
Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
|
|
|
2019
|
7 |
5 |
p. 385-396
|
artikel
|
| 19 |
Low-carbohydrate diets in type 2 diabetes
|
Tay, Jeannie
|
|
2019
|
7 |
5 |
p. 331-333
|
artikel
|
| 20 |
New pharmacological strategies for protecting kidney function in type 2 diabetes
|
Muskiet, Marcel H A
|
|
2019
|
7 |
5 |
p. 397-412
|
artikel
|
| 21 |
Rational combination therapy for type 2 diabetes
|
Del Prato, Stefano
|
|
2019
|
7 |
5 |
p. 328-329
|
artikel
|
| 22 |
Research in brief
|
McIntosh, Kate V
|
|
2019
|
7 |
5 |
p. 342
|
artikel
|
| 23 |
Retraction and republication—Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial
|
The Editors of The Lancet Diabetes & Endocrinology,
|
|
2019
|
7 |
5 |
p. 334
|
artikel
|
| 24 |
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
|
Zinman, Bernard
|
|
2019
|
7 |
5 |
p. 356-367
|
artikel
|
| 25 |
The things that make us human
|
Stirrups, Robert
|
|
2019
|
7 |
5 |
p. 343
|
artikel
|
| 26 |
Type 2 diabetes: treating not managing
|
Morris, Elizabeth
|
|
2019
|
7 |
5 |
p. 326-327
|
artikel
|
Tijdschrift beschrijving